Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-23-004092

Options or other derivatives

  • Chief Financial Officer acquired 163,996 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gerber Brianna · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-15 Grant or award : show line 1 in the form Employee Stock Options (right to buy) +163,996 163,996 D
Loading xslF345X03/wf-form4_167667171935135.xml…